The projected value of the global generics market by 2023 is $474B, up from $240B in 2017. This is the reason why numerous companies are now focusing more attention on the generic industry and API manufacturing business, particularly in the US market where more than 600 products are under active litigation. Newport, a Cortellis solution, can help you assess your market and identify business opportunities in this industry. For instance, in a few clicks you can identify the names of the drugs selling over $100M for different regions around the world, estimated to go generic by the end of 2024.
During this session you will learn how Newport can help you: